# PROGRESS.md — NBEO Study Platform

> Update this file at the end of every work session with exactly what's done and
> exactly what's next. Be specific — a future session (yours or someone else's) has
> no memory of this conversation and must be able to pick up from this file alone,
> plus PROJECT_SPEC.md and the current nbeo-app.jsx.

## READ THIS FIRST — session of 2026-08-19: full accuracy audit, mobile layout, GitHub Pages deploy

The user asked for every topic's study content to be double-checked for
(1) factual accuracy against real optometry/medical references and (2)
completeness against the official NBEO outline, with errors fixed and
real gaps filled — "double check against the NBEO content matrix to
ensure everything was covered."

**Method**: split all 266 built topics into 16 chunks by condition
area (splitting the huge Systemic Health area into 5 sub-chunks by
discipline, and further splitting its 24-topic Pathology sub-chunk and
one 20-topic chunk in half after one agent run hit a usage-limit
mid-task). Each chunk was audited by a fresh subagent instructed to:
read the topic's `objs[]` in `CURRICULUM` (the real NBEO outline text)
as ground truth, verify every existing fact/formula/mechanism against
standard references, fix errors in place, and add new objectives/
STUDY_PAGES/flashcards for any `objs[]` item with zero real coverage.
Every chunk's output was independently re-validated here (babel syntax
check, `integrity_check.py`, spot-checking at least one specific claimed
fix or calculation by hand) before committing — nothing was trusted
blind. One chunk (Cornea/Conjunctiva) had to be re-run after a partial
first attempt hit a usage limit; its safe partial progress was checkpointed
and the re-run picked up from there without duplicating work.

**Real errors found and fixed** (not just gaps — these were actively
wrong before this session):
- Schematic Eye Models: reduced-eye worked examples paired n'=1.336 with
  a 22.22mm axial length that only matches n'=4/3 — internally
  inconsistent math, now fixed throughout.
- EOM physiology: yoke-muscle pairing mislabeled "R inferior oblique + L
  superior rectus" as the down-and-left gaze pair; it's up-and-left.
- Retina/Vitreous pharmacology: aflibercept was described as an antibody;
  it's a VEGFR1/VEGFR2-Fc fusion protein. Faricimab (bispecific VEGF-A +
  Ang-2 antibody) was missing entirely.
- Retinal Gross Anatomy: the "ten layers" list double-counted
  photoreceptor segments while omitting the ILM from the numbered ten.
- Optic Nerve pupillary pathway: Horner syndrome pharmacologic testing
  conflated "confirms the diagnosis" (cocaine/apraclonidine) with
  "localizes the lesion" (only hydroxyamphetamine does that) — corrected,
  and the missing hydroxyamphetamine test was added.
- Autonomic pathway anatomy: pilocarpine pupil-testing logic was
  backwards — it now correctly says pilocarpine constricts a CN III-palsy
  pupil (denervated but intact sphincter) but NOT a pharmacologically-
  blocked pupil (receptors already occupied).
- Systemic Health Pharmacology: vague "certain agents" language for
  antipsychotic ocular side effects replaced with the correct named
  drugs (thioridazine → pigmentary retinopathy; chlorpromazine →
  corneal/lens deposits).
- Glaucoma: steroid-response and uveitic glaucoma were referenced as
  "already covered under Glaucoma content" from ~10 other places in the
  app but had never actually been built — added as real objectives.

**Gaps filled**: roughly 150 new objectives/STUDY_PAGES entries added
across all 16 chunks for `CURRICULUM.objs[]` items that had zero real
coverage anywhere in the app — too many to list individually here; see
each chunk's commit message (search git log for "Accuracy + coverage
audit") for the specific list per condition area. Notable high-yield
ones: subjective/objective refraction technique, laser-tissue
interaction, allergic conjunctivitis (SAC/PAC/VKC/AKC), lung cancer,
anaphylaxis, cardiovascular EKG/hemostasis, cerebrum white matter/Meyer's
loop, rhino-orbital-cerebral mucormycosis, and ocular toxoplasmosis (the
most common infectious cause of posterior uveitis).

**Final state**: 710 objectives, 710 study pages, 1,777 flashcards, 355
questions, 266 content topics — `integrity_check.py` zero orphans/
duplicates, `audit_coverage.py` all 16/16 condition areas COMPLETE.

**Other work this session**:
- **NBEO Blueprint topic dropdowns** (see part-2 entry below) — carried
  forward from the previous session, unaffected by this one.
- **Learn tab reorganized** by condition area → discipline (accordion,
  mirrors Blueprint's grouping) instead of one flat list of ~90 topics.
- **Merged the working branch to `main`** — `main` is now the canonical,
  actively-developed branch; the old `claude/nbeo-coverage-refactor-i8ionz`
  branch's job is done.
- **Deployment**: added a Vite build (`package.json`, `vite.config.js`,
  `index.html`, `src/main.jsx`) so the app can be built and hosted.
  Netlify was set up first but the user hit a billing prompt on their
  account, so the primary deploy path is now **GitHub Pages via GitHub
  Actions** (`.github/workflows/deploy-pages.yml`) — free, no card, ties
  into the existing GitHub account. Deploys automatically on every push
  to `main` once the user sets Settings → Pages → Source → "GitHub
  Actions" (one-time manual step, already requested). `vite.config.js`'s
  `base` is conditional on `GITHUB_ACTIONS` so local dev still serves
  from `/` while the Pages build serves from `/NBEO-App/`.
- **Mobile-responsive redesign**: the app shell had a fixed 232px sidebar
  with zero breakpoints, unusable on a phone. It now converts to a
  slide-in drawer (hamburger + sticky top bar) under 860px width, closes
  on nav selection, plus wrap-instead-of-overflow fixes for Blueprint/
  Learn's accordion rows and a horizontal-scroll wrapper for Dashboard's
  coverage table. Verified with Playwright on an iPhone 13 viewport:
  zero horizontal overflow, zero console errors.

**What's actually left**: nothing structurally missing — 100% topic
coverage, and this session's audit means every topic has now been
checked at least once for accuracy and outline-completeness. Reasonable
next steps if the user wants to keep improving: (1) a second audit pass
focused specifically on calculation-heavy topics with fresh arithmetic
re-verification, since CLAUDE.md requires that for every calculation
question and this session's agents self-verified but a second
independent pass never hurts; (2) polish remaining mobile screens beyond
Dashboard/Blueprint/Learn (Flashcards/Questions/study-page detail views
weren't specifically screenshot-tested on mobile this session, though
they use simpler layouts less likely to overflow); (3) the "Exams,"
"Images," "Study Planner," "Mistakes," "Analytics," "AI Tutor" nav items
are still "coming soon" placeholders — build out if the user wants them.

## READ THIS FIRST — session of 2026-08-18 (part 2): Blueprint objective dropdowns

The user asked for the NBEO Blueprint page's topic bullets (e.g. under
"Ametropia" → "Optics (Geometrical)" → "Refraction at single spherical/plane
surfaces") to be expandable, showing the actual text of each numbered
objective instead of just the `N obj.` count. They first attached a PDF
that turned out to be just the 1-page summary blueprint table (area names +
item-count ranges) — same info already in `CURRICULUM`, no objective text.
After being told this, they attached the correct document: the real
**"Part I ABS Exam Content Outline – Discipline-Based" PDF (44 pages)**,
which lists every topic's lettered heading (A., B., C., …) with its
numbered knowledge objectives (1., 2., 3., …) underneath, plus deeper
lettered/roman-numeral sub-detail in places (a., i., ii., …).

What was done:
- Extracted the PDF's text with `pypdfium2` (pdfplumber/pdftotext were
  broken in this environment — a `cryptography`/rust `_cffi_backend` import
  panic and missing `poppler-utils` respectively — `pypdfium2`'s own text
  extraction worked cleanly).
- Wrote a parser (`parse_outline.py`, kept only in the session scratchpad,
  not the repo) that walks the extracted text and recognizes three line
  types: `Discipline (Sub): Area` section headers, `X. Topic name` lettered
  topic headers, and `N. Objective text` numbered objectives. Everything
  else (lettered/roman sub-bullets, wrapped continuation lines) folds into
  whichever objective/topic is currently open, joined with `; ` for a new
  sub-bullet marker or a plain space for line-wrap continuation — this
  matches the file's own documented rule that `o:` only counts the
  numbered (1,2,3…) level, not the deeper lettered/roman detail beneath it.
- Parsed 60 sections / 266 topics / 996 numbered objectives — the *exact*
  same 60/266 as the existing `CURRICULUM` array. Cross-checked every
  topic by `(area, discipline)` pairing (not raw document order — the PDF
  is discipline-grouped top-to-bottom, `CURRICULUM` is area-grouped, so a
  positional check across the whole file gives false mismatches; grouping
  by the `(area, discipline)` key first is required). Result: 266/266
  topics matched, all `o` counts matched exactly except topics whose `o: 1`
  has no numbered breakdown in the source (expected — see below).
- Regenerated the `CURRICULUM` array with a new `objs: [...]` field added
  to every topic (array of objective-text strings; `[]` when the topic's
  single objective has no numbered breakdown in the source). Verified via
  a Node script that every existing `area`/`major`/`range`/`d`/`n`/`o`
  value is byte-identical to before — only `objs` was added, nothing else
  changed.
- Updated the `Blueprint` component: topic bullets with `objs.length > 0`
  are now clickable (chevron replaces the static dot), toggling a nested
  numbered list of the real objective text; topics with no breakdown stay
  static, matching the source (the bullet name already *is* their one
  objective).
- Rebuilt and Playwright-tested `nbeo-app-preview.html` against the change
  (screenshot-verified expand/collapse in both the Ametropia and Systemic
  Health areas, including the 4-level-deep "Tissue types" topic under
  Anatomy (Histology)); zero console errors.
- Validated with `integrity_check.py` (unaffected — still 592/592/1402/310/266,
  zero orphans/duplicates) and `audit_coverage.py` (still 266/266).
- Updated `PROJECT_SPEC.md`'s "Known open questions" — the note about no
  official source document ever being uploaded is now resolved and
  replaced with what was done, and the `CURRICULUM` shape description now
  documents the `objs` field.

**If a future session adds a new topic to `CURRICULUM` by hand, it must
include an `objs` array (real objective text, or `[]` if genuinely none)**
— the Blueprint UI assumes every topic has this key.

## READ THIS FIRST — session of 2026-08-18: 266/266 (100%) COMPLETE

**`audit_coverage.py` reports 266/266 topics built, 0 remaining.** This
session started at 138/266 (the last-known state below) and closed every
remaining gap in a single continuous run: **128 new topics**, ~232 new
objectives, ~356 new study-page learnIt/memorizeIt/applyIt writeups, ~262
new flashcards, and ~53 new practice questions, across **20 commits**, all
pushed to `claude/nbeo-coverage-refactor-i8ionz`.

**Every condition area is COMPLETE**, including Systemic Health: Ametropia,
Ophthalmic Optics/Spectacles, Contact Lenses, Low Vision, Accommodation/
Vergence, Amblyopia/Strabismus, Perceptual Function/Color Vision, Visual &
Human Development, Lids/Lashes/Lacrimal/Orbit, Conjunctiva/Cornea/
Refractive Surgery, Lens/Cataract/IOL, Episclera/Sclera/Anterior Uvea,
Vitreous/Retina/Choroid, Optic Nerve/Neuro-Ophthalmic Pathways, Glaucoma,
Systemic Health.

**The last 3 topics were closed with genuinely new content, not a
remapping of previously-merged material.** Earlier in this same session
(and in prior sessions, see "Caveat on Pathology's earlier '100% swept'
claim" and "Complement's intentionally-skipped standalone slot" notes
further down this file), `t-15-5-3` (Complement), `t-15-7-1` (Inflammation
and repair), and `t-15-7-4` (Cellular disease) were treated as
false-positive audit flags because their general subject matter already
existed under `antibody-function`/`nonspecificimm-complement` and Host
Defenses. The user then explicitly asked for 100% coverage, so these three
were built as real, distinct, non-redundant topics instead of leaving them
as documented exceptions:
- **`complement-regulatory-proteins` / `complement-cfh-amd`** — complement
  regulatory proteins (Factor H, Factor I, CD55, CD59) and, specifically,
  the Complement Factor H Y402H polymorphism as a major genetic AMD risk
  factor. Genuinely new angle (regulation + AMD genetics) vs. the
  already-built activation-pathway content; ties directly into existing
  AMD, Choroidal Layers, and Anti-VEGF Therapy content.
- **`repair-wound-healing-phases` / `repair-healing-complications`** — the
  four-phase wound healing sequence (hemostasis → inflammation →
  proliferation → remodeling), primary vs. secondary intention, and
  complications (keloid vs. hypertrophic scar, dehiscence, chronic
  wounds). Genuinely new angle (the repair PROCESS) vs. the already-built
  inflammation MECHANISM under Host Defenses; ties into existing Diabetes
  Mellitus/Atherosclerosis (chronic wound risk) and Cataract Surgery
  (primary-intention healing) content.
- **`celldisease-adaptation-types` / `celldisease-dysplasia-neoplasia`** —
  reversible cellular adaptation (hypertrophy, hyperplasia, atrophy,
  metaplasia) and dysplasia as a genuine pre-neoplastic lesion. Genuinely
  new angle (adaptation BEFORE injury, and the metaplasia→dysplasia→
  neoplasia progression) vs. the already-built necrosis/apoptosis content
  under Host Defenses; ties into existing Hypertension (cardiac
  hypertrophy) and Neoplasia/Oncogenes content.

The previously-merged content these three topics originally lived under
(Antibody Function & Complement Activation, Nonspecific Immunity's
Complement System, and Host Defenses' inflammation/cell-injury
objectives) was left completely unchanged — nothing was removed or
remapped, only added.

`integrity_check.py` passes clean (zero orphans, zero duplicates) and a
full Babel syntax check passes as of the final commit on this branch.
Every topic added this session follows PROJECT_SPEC.md's content-shape
rules (disease-mechanism / structural-localization / calculation-based as
appropriate) and cross-references existing built content — see the commit
log on `claude/nbeo-coverage-refactor-i8ionz` for a per-batch breakdown.

**What's actually left — nothing for structural coverage. Everything below
is quality/infrastructure work beyond the original "100% coverage" goal:**
1. **The file-splitting question, deferred twice now.** The user was
   asked whether to split `nbeo-app.jsx` (now ~2.75MB, ~23,300 lines) into
   per-topic source files with a build step, versus staying monolithic —
   chose to stay monolithic both times it came up. Worth re-raising now
   that the file is at its largest and coverage work is fully done, since
   the fragility risk PROJECT_SPEC.md flags has only grown and there's no
   more "just one more topic" reason to delay.
2. **The source-verification pass.** Every study page's `verification`
   field is still `"UNDER REVIEW"` — nothing has been fact-checked against
   an authoritative source. This was always a known, deferred task (see
   "Open questions" below) and is now THE largest remaining piece of real
   work if the platform is to claim verified accuracy rather than just
   structural completeness. With structural coverage done, this is
   probably the highest-value next project.
3. **Emergencies/Trauma tagging** — still an open question, see below.
   Not addressed this session; the outline treats it as embedded across
   other topics rather than a standalone section, so this needs a
   decision (dedicated topic vs. weaving into existing content) more than
   it needs new topic slots.
4. A live React preview of the app was published as a Claude Artifact
   this session (bundling React 18 + reimplemented lucide icons, since
   there's still no npm/build project in this repo — see point 1). Along
   the way, a real latent bug was found and fixed *in the preview
   bundling code only* (not in `nbeo-app.jsx` itself): naming an icon
   component `Map` at global script scope silently shadows the built-in
   `Map` constructor. This has no effect on `nbeo-app.jsx` as consumed by
   a real bundler (webpack/Vite scope every module), so no source change
   was needed — noted here only so a future session doesn't waste time
   rediscovering it if this file is ever loaded via plain `<script>` tags.
   The bundled preview HTML (`nbeo-app-preview.html`, ~2.7MB) is committed
   to the repo root as a generated artifact — regenerate it rather than
   hand-editing it if `nbeo-app.jsx` changes and a fresh preview is
   needed.

**Numbers below this point (138/266, "130 remaining", per-area stats,
etc.) describe the state BEFORE this session and are now stale.** They're
left in place as historical record per this file's own instructions, but
`audit_coverage.py`'s live output is — as always — the ground truth.

---

## Current stats (as of last session)
- **266/266** curriculum topics mapped (structure complete, this part is done forever)
- **138/266** topics have real content — **all 138 are 100% complete**
- **400** study pages written
- **1137** flashcards written
- **260** practice questions written (each with full per-choice explanations,
  including genuine worked-calculation problems — Prentice's rule, SAM-FAP
  contact lens power, reduced-eye focal length, far-point spectacle power,
  Snellen-to-MAR conversion, single-surface vergence, thin-lens image
  formation/magnification, prism deviation/combination, spherocylindrical
  transposition, obliquely-crossed cylinder combination, and Malus's law
  polarization intensity. All calculation answer keys have been
  independently verified with a Python arithmetic check before being
  written into the file — do this for every new calculation question.)
- **NOTE ON TOPIC COUNT**: earlier session notes said "264 total" — a full
  structural audit (parsing the CONTENT_TOPICS_TREE in nbeo-app.jsx
  directly) found the true total is 266 leaf topics. Trust the audit
  script's output (see below) over any hardcoded number in prose.
- All cross-references validated (zero orphaned objectiveIds, zero duplicate keys,
  zero duplicate topic ids, zero built:false among started topics) — verified via
  a new reusable Python integrity script (`/home/claude/integrity_check.py` this
  session; re-create it in future sessions if not carried over, logic described
  below in "Validation tooling") and a Babel-based JSX syntax check.
- File size: nbeo-app.jsx is over 500KB (babel cosmetic note only, not an error).
- User does NOT want PROGRESS.md presented every turn — only update/present when
  explicitly asked. User also wants briefer chat summaries (report generally).
  User confirmed no urgency on covering untouched disciplines, and does NOT
  mind redundant content across topics — priority is full board-exam coverage,
  not strict non-duplication. Keep going with current approach at a
  comfortable pace.
- **MILESTONE this session: Systemic Health Neuroanatomy sub-discipline is
  now 100% COMPLETE — all 9 topics built** (Diencephalon, Neurohistology,
  Autonomic NS, Medulla, Pons, Midbrain [prior turns], plus Cerebrum,
  Cerebellum, Blood Supply, and Spinal Cord [this turn]). This is a fully
  integrated brainstem-through-cortex neuroanatomy sequence: cranial nerve
  nuclei at each brainstem level (Medulla/Pons/Midbrain), cortical
  organization (Cerebrum's visual cortex/FEF), vascular territories (Blood
  Supply, tying Circle of Willis to specific stroke syndromes), and spinal
  cord tract organization (explaining the crossed sensory pattern in
  Wallenberg syndrome via differential tract-crossing levels) — culminating
  in a genuinely integrated stroke/lesion-localization framework spanning
  the entire session's content. The structural/localization content shape
  (Apply It sections focused on "what deficit results from damage here")
  proved highly effective across all 9 topics.
- **MILESTONE this session (continued): Corrected another stale
  PROGRESS.md claim and closed a genuine gap.** Ophthalmic Optics/
  Spectacles was previously assumed to be "genuinely likely empty" — this
  was WRONG; grep-verification found 6 topics already built (Optical
  Characteristics of Ophthalmic Lenses, Ophthalmic Prisms/Prentice's Rule,
  Multifocal Lenses, Frame Fitting, High-Powered Lens Considerations,
  Impact Resistance/ANSI standards). The one genuine remaining gap —
  Reflection (t-1-2-1) — was built this session: Anti-Reflective Coating —
  Mechanism & Clinical Trade-offs (applies the destructive-interference
  principle already covered under Wave Optics to a concrete dispensing
  context, explains why AR coating benefit scales with lens index via the
  Fresnel reflection principle already covered) and Mirror Coatings &
  UV-Reflective Treatments (establishes that tint, mirror coating, and UV
  protection are three INDEPENDENTLY specified lens properties — a
  genuinely important patient-safety counseling point, since a
  dark/mirrored lens does not automatically guarantee adequate UV
  protection). **Two consecutive stale-claim corrections this session
  (Contact Lenses/Low Vision earlier, Ophthalmic Optics/Spectacles now)
  reinforce that PROGRESS.md's prose "coverage status" claims should be
  treated as provisional and grep-verified before being trusted,
  especially for areas not touched in several sessions.**
- **Caveat on Pathology's earlier "100% swept" claim — RESOLVED this
  session.** Investigated the discrepancy flagged in the prior session note
  below: grep-verified that Pathology has 22 distinct topic IDs built
  (t-15-7-0 through t-15-7-23, excluding indices 1 and 4). Confirmed
  indices 1 ("Inflammation and repair") and 4 ("Cellular disease") were
  DELIBERATELY merged into the Host Defenses topic (t-15-7-3) in an earlier
  session — its objectives (host-phagocytosis, host-cell-injury,
  host-inflammation) already cover this content, so no true gap existed
  there. The genuinely unbuilt subtopics were: Head and Neck (pathology,
  distinct from the Anatomy Head & Neck topic), Congenital/Hereditary
  Conditions, Anomalies of Child Development (systemic, distinct from the
  Visual & Human Development area's version), and Anomalies of the Aging
  Adult (systemic, distinct from the Visual & Human Development area's
  version) — all 4 built this session (8 new objectives: Sinusitis & Its
  Orbital Complications, Salivary Gland & Thyroid Nodule Pathology,
  Neurofibromatosis, Tuberous Sclerosis Complex, Fetal Alcohol Spectrum
  Disorder, Failure to Thrive, Frailty & Fall Risk, Polypharmacy). **Systemic
  Health Pathology is therefore now GENUINELY, VERIFIED 100% complete — all
  8 disciplines of Systemic Health are confirmed done.** This is a real,
  fully-verified milestone: Systemic Health (the largest single major
  condition area) is completely finished.

## Fully complete topics (all objectives built) — 13 of 13 started topics
1. Endocrine / Metabolic System — 11/11
2. Nervous System & Neuromuscular Diseases — 10/10
3. Integumentary System — 7/7
4. Glaucoma — 8/8
5. Cornea / External Disease — 8/8 (Conjunctiva/Cornea/Refractive Surgery — biggest area)
6. Retina / Vitreous — 8/8
7. Neuro-Ophthalmic Disorders (Optic Nerve) — 5/5
8. Lids, Lacrimal System & Orbit — 6/6 (finished this session: Ectropion/Entropion,
   Ptosis differential, Dacryocystitis/NLDO)
9. Uvea, Sclera & Episclera — 5/5 (finished this session: Posterior Uveitis/
   Panuveitis, JIA/Sarcoid-associated uveitis)
10. Lens & Cataract — 6/6 (finished this session: Congenital Cataract, Cataract
    Surgery, IOL Power Calculation)
11. Amblyopia & Strabismus — 5/5 (finished this session: Anomalous Retinal
    Correspondence/Suppression, CN III/IV/VI Palsies)
12. Cardiovascular System — 5/5 (finished this session: CHF, Arrhythmias)
13. Hematopoietic & Lymphoid System — 4/4 (finished last session: Lymphoma)
14. Ametropia — Refractive States — 5/5 (Myopia, Hyperopia, Astigmatism,
    Presbyopia, Anisometropia)
15. Ametropia — Anomalies of Refraction — 3/3 (built this session: Aphakia,
    Pseudophakia, Aniseikonia — completes core Ametropia refractive coverage)
16. Genetic Principles & Disorders — 4/4 (finished this session: Mitochondrial
    Disorders, incl. LHON and CPEO)
17. Immunologic System — 4/4 (finished this session: Hypersensitivity Reactions
    Types I-IV)
18. Respiratory System — 5/5 (finished this session: Pneumonia, Interstitial
    Lung Disease/Pneumoconiosis)
19. Musculoskeletal System — 4/4 (finished this session: Osteoarthritis)
20. Gastrointestinal System — 4/4 (finished this session: Cirrhosis/Liver
    Failure)
21. Renal & Urogenital System — 4/4 (finished this session: Glomerulonephritis)
22. Liver & Biliary Tract — 3/3 (finished this session: Primary Biliary
    Cholangitis)
23. Neoplasia (General Oncology) — 4/4 (finished this session: Oncogenes &
    Tumor Suppressor Genes)
24. Mental Illness & Behavioral Disorders — 4/4 (finished this session:
    Schizophrenia & Bipolar Disorder)
25. Nutrition — 4/4 (finished this session: Obesity & Metabolic Syndrome)
26. Reproductive System — 4/4 (finished this session: Breast Cancer)
27. Color Vision — 4/4 (finished this session: Color Mixture & Opponent-Process
    Theory)
28. Accommodation & Vergence Disorders — 3/3 (finished this session: Vergence
    Anomalies — convergence excess, divergence insufficiency)
29. Contact Lens Complications — 4/4 (finished this session: Solution
    Toxicity & Sterile Infiltrates)
30. Low Vision — 3/3 (own full condition area: Classification/Epidemiology,
    Examination/Testing, Devices/Rehabilitation)
31. Visual Development & Child Anomalies — 3/3 (own condition area:
    Developmental Milestones & Screening, Cortical Visual Impairment (CVI),
    Infantile Nystagmus)
32. Changes in Vision with Aging — 3/3 (Dark Adaptation & Glare Sensitivity,
    Senile Miosis & Pupillary Changes, Age-Related Contrast Sensitivity &
    Visual Processing Changes)
33. Space Perception & Depth Cues — 3/3 (Binocular Depth Cues/Stereopsis,
    Monocular Depth Cues, Clinical Testing of Stereopsis & Depth Perception)
34. Form Perception — 3/3 (Visual Acuity Specification & Measurement,
    Contrast Sensitivity Function, Spatial Interactions)
35. Light Perception — 3/3 (Dark & Light Adaptation Processes, Light Detection
    Thresholds & Weber's Law, Spatial & Temporal Summation)
36. Motion Perception — 3/3 (Real & Apparent Motion Detection, Dynamic Visual
    Acuity, Motion Aftereffects & Clinical Relevance)
37. General Health — 3/3 (Differential Diagnosis of Common Systemic Symptoms,
    Common Systemic Medication Side Effects, Basic Cardiac Life Support &
    Preventive Medicine)
38. Host Defenses & Cellular Disease — 3/3 (Phagocytosis & Innate Immune
    Defenses, Cell Injury & Death, Acute vs. Chronic Inflammation Mechanisms —
    this completes the full sweep of Systemic Health Pathology topics)
39. Effects of Early Environmental Restrictions — 3/3 (Critical Period
    Plasticity & Animal Models, Monocular vs. Binocular Deprivation Effects,
    Clinical Causes of Deprivation — synthesizes Congenital Cataract, Ptosis,
    Anisometropia, and Strabismus under one shared mechanism)
40. Spectacle Fitting & Lens Selection — 3/3 (Frame Fitting Complications &
    Adjustment, Multifocal Lens Adaptation Issues, Absorptive & Photochromic
    Lens Considerations)
41. Ophthalmic Prisms & Prismatic Effects — 3/3 (Prism Diopter & Prentice's
    Rule, Prism Prescribing for Diplopia & Vergence Disorders, Fresnel
    Press-On Prisms)
42. Multifocal Lens Design — 3/3 (Bifocal & Trifocal Segment Types, Image
    Jump & Displacement, Progressive Addition Lens Design Principles)
43. High-Powered Lens Considerations — 3/3 (Aspheric Lens Design & Benefits,
    High-Index Materials & Considerations, Lenticular Lenses for High Plus
    Power — ties directly back to Aphakia)
44. Impact Resistance & Optical Standards — 3/3 (ANSI Z80/Z87 & FDA Impact
    Standards, Lens Material Impact Safety Comparison, Occupational &
    Pediatric Eyewear Safety Requirements — ties to Amblyopia)
45. Optical Characteristics of Ophthalmic Lenses — 3/3 (Lens Forms & Base
    Curve Selection, Oblique Astigmatism & the Tscherning Ellipse, Reflection
    & Anti-Reflective Coatings)
46. Vision Development in the Infant/Child — 3/3 (Emmetropization,
    Accommodative Development, Stereopsis & Binocular Vision Development
    Timeline)
47. Vision Perceptual-Motor Skills — 1/1 (Visual-Motor Integration &
    Learning-Related Vision — completes the entire Visual and Human
    Development area)
48. Contact Lens Fitting & Selection — 3/3 (RGP vs. Soft Lens Selection
    Criteria, Fitting Parameters & Assessment, Specialty Contact Lens
    Designs — Toric, Scleral, Multifocal)
49. Optical Characteristics of Contact Lenses — 3/3 (Tear Lens Power & Base
    Curve Effects, Vertex Distance Conversion for Contact Lenses, Contact
    Lens Power Calculation — SAM-FAP Rule — includes worked calculations)
50. Contact Lens Pharmacology — 2/2 (Multipurpose Solutions vs. Hydrogen
    Peroxide Systems, Indications/Contraindications & Drug Interactions —
    completes near-full coverage of the Contact Lenses area)
51. Tear Film & Lacrimal Physiology — 3/3 (FIRST Physiology-discipline topic:
    Tear Film Structure & Layers, Lacrimal Secretion & Blink-Mediated
    Distribution, Tear Drainage System Physiology — natural entry point
    extending existing Dry Eye/Sjögren/MGD disease content)
52. Eyelid Physiology — 3/3 (Blink Reflex Mechanics & Neural Control,
    Meibomian Gland Function & Lipid Secretion, Eyelid Protective Functions
    — Bell's Phenomenon, Corneal Coverage)
53. Extraocular Muscle Physiology — 3/3 (EOM Actions & Fields of Gaze,
    Hering's Law & Sherrington's Law, Yoke Muscles & Versional Eye
    Movements — gives mechanistic grounding to the primary/secondary
    deviation finding in Cranial Nerve Palsy content. Completes the entire
    Physiology section for the Lids/Lacrimal/Adnexa/Orbit area.)
54. Aqueous Humor Dynamics — 3/3 (Aqueous Humor Production & Composition,
    Aqueous Outflow Pathways — Trabecular vs. Uveoscleral, IOP Regulation &
    Diurnal Variation — organizes Glaucoma medication mechanisms)
55. Corneal Physiology — 3/3 (Corneal Transparency Mechanisms, Endothelial
    Pump Function & Cell Density, Corneal Metabolism & Oxygen Requirements —
    completes the full mechanistic chain behind Contact Lens Hypoxia
    content, and adds surgical risk reasoning via endothelial cell density
    to Cataract/IOL content)
56. Intraocular Pressure Measurement — 3/3 (Tonometry Methods —
    Applanation, Non-Contact, Rebound, Episcleral Venous Pressure & IOP
    Floor, Corneal Biomechanics & Measurement Accuracy — adds a third
    distinct glaucoma mechanism (elevated EVP) and a real patient-safety
    point about post-LASIK tonometry underestimating true IOP. Completes
    Glaucoma's entire Physiology section.)
57. Photoreceptor & RPE Physiology — 3/3 (Phototransduction Cascade, The
    Visual (Retinoid) Cycle & RPE Function, Rod-Cone Differences &
    Adaptation Mechanisms — gives the biochemical basis for AMD's
    RPE-centered pathophysiology and connects dark adaptation, retinitis
    pigmentosa's symptom pattern, and foveal cone exclusivity into one
    coherent picture)
58. Vitreous Physiology — 3/3 (Vitreous Composition & Structure, Vitreous
    Aging & Syneresis, Posterior Vitreous Detachment Mechanics — gives the
    complete mechanistic story behind the classic flashes-and-floaters
    presentation in Retinal Detachment content, and explains elevated RD
    risk in myopic patients via accelerated syneresis. Completes
    Vitreous/Retina/Choroid's entire Physiology section.)
59. Crystalline Lens Physiology — 3/3 (Lens Transparency & Crystallin
    Proteins, The Accommodation Mechanism (Helmholtz Theory), Presbyopia:
    The Physiologic Basis for Lens Stiffening — genuine unifying insight:
    presbyopia and nuclear sclerotic cataract share the same root cause,
    lifelong non-renewable lens fiber cell accumulation, just manifesting
    as different clinical problems)
60. Ciliary Body & Iris Physiology — 3/3 (Ciliary Body Secretory Function &
    Autonomic Control, Pupillary Light & Near Reflexes, Iris Pigmentation &
    the Blood-Aqueous Barrier — pinpoints the specific cellular targets
    behind beta-blocker/CAI Glaucoma medications, and gives the physiologic
    basis for flare/cell as a real measure of Uveitis activity. Completes
    Episclera/Sclera/Anterior Uvea's entire Physiology section.)
61. Visual Pathway Physiology — 3/3 (Optic Chiasm Decussation &
    Retinotopic Organization, Lateral Geniculate Nucleus & Visual Cortex
    Processing, Visual Field Defect Localization Along the Pathway — a
    genuinely high-yield clinical reasoning skill: stepwise localization
    from monocular → bitemporal → homonymous, then quadrant/congruity,
    directly applicable to Pituitary and Stroke content)
62. Optic Nerve Neurophysiology — 3/3 (Axonal Conduction & Saltatory
    Conduction, Myelination & the Optic Nerve's CNS Classification, Effects
    of Demyelination on Conduction — establishes that optic neuritis is
    mechanistically, not just statistically, the same disease process as
    MS via shared oligodendrocyte/CNS myelin biology, and gives Uhthoff's
    phenomenon as a physiologically-grounded diagnostic clue)
63. Pupillary Pathway Clinical Testing — 3/3 (Relative Afferent Pupillary
    Defect (RAPD/Marcus Gunn Pupil), Anisocoria Differential Diagnosis,
    Horner Syndrome & the Oculosympathetic Pathway — completes the ENTIRE
    Physiology section for Optic Nerve/Neuro-Ophthalmic Pathways;
    high-yield clinical testing content: the bright-light-vs-dim-light
    anisocoria algorithm, why cataract never causes RAPD, carotid
    dissection as a Horner emergency)
64. Cardiovascular Physiology — 3/3 (Cardiac Conduction System & the
    Cardiac Cycle, Blood Pressure Regulation — Baroreceptors/RAAS, Cardiac
    Output & Frank-Starling Mechanism — gives the precise molecular targets
    behind Hypertension medications (ACE inhibitors, ARBs) and explains why
    diuretics remain essential in Heart Failure)
65. Endocrine Physiology — 3/3 (Hypothalamic-Pituitary Axes & Negative
    Feedback, Thyroid Hormone Synthesis & Regulation, Insulin/Glucagon &
    Glucose Homeostasis — the primary-vs-secondary hormone-pairing
    framework applies across Adrenal, Thyroid, and any HPA-patterned axis;
    also explains radioactive iodine therapy mechanism and the upstream
    cause of diabetic retinopathy)
66. Respiratory Physiology — 3/3 (Gas Exchange & Ventilation-Perfusion
    Matching, Oxygen-Hemoglobin Dissociation Curve, Control of
    Breathing/Chemoreceptors — V/Q mismatch unifies pneumonia, COPD, asthma,
    and PE hypoxemia under one framework; flags that pulse oximetry can be
    falsely reassuring in severe anemia since it measures saturation, not
    total oxygen content; explains cautious O2 titration in chronic
    CO2-retaining COPD patients)
67. Gastrointestinal Physiology — 3/3 (built this session: GI Motility & the
    Enteric Nervous System, Gastric Acid Secretion & Regulation — the
    three-pathway ACh/gastrin/histamine framework directly explains PPI vs.
    H2-blocker relative potency, Digestion & Absorption — ties bile/fat-
    soluble vitamin K malabsorption to the existing Cirrhosis coagulopathy
    content)
68. Renal Physiology — 3/3 (built this session: Glomerular Filtration & GFR
    Regulation — explains ACE-inhibitor/ARB renoprotection in diabetic
    nephropathy via efferent arteriolar dilation, Renal Tubular Function &
    Reabsorption — maps diuretic drug classes to their exact tubular site of
    action, Renal Acid-Base Regulation — explains chronic metabolic acidosis
    in CKD and the acetazolamide side-effect mechanism)
69. Muscle Physiology — 3/3 (built this session: Skeletal Muscle Contraction
    & the Sliding Filament Mechanism — ties dystrophin's structural role to
    existing Muscular Dystrophy content, Neuromuscular Junction
    Transmission — gives the precise receptor-depletion mechanism behind
    Myasthenia Gravis's fatigable weakness and acetylcholinesterase
    inhibitor therapy, Muscle Fiber Types & Energy Metabolism — connects to
    existing Extraocular Muscle Physiology's specialized mixed fiber
    composition)
70. Nerve Cell Electrophysiology — 3/3 (built this session: Resting Membrane
    Potential & the Nernst Equation, Action Potential Generation &
    Propagation, Synaptic Transmission — completes the biophysical
    foundation beneath existing Optic Nerve Neurophysiology and MS/
    demyelination content, and explicitly parallels the NMJ mechanism
    already covered under Muscle Physiology)
71. Cellular Physiology — 3/3 (built this session: Cell Membrane Transport
    Mechanisms — ties the corneal endothelial pump to primary active
    transport physiology, Cellular Respiration & ATP Production — explains
    why Mitochondrial Disorders (LHON, CPEO) preferentially affect
    high-energy-demand tissues, Cell Cycle & Its Regulation — gives the
    checkpoint-level mechanistic basis for existing Oncogenes & Tumor
    Suppressor Genes content)
72. Body Fluids & Electrolyte Physiology — 3/3 (built this session: Fluid
    Compartments & Osmotic Regulation, Edema — Physiologic Mechanisms —
    unifies the edema seen in existing CHF/Nephrotic Syndrome/Cirrhosis
    content under one Starling-forces framework, showing each disrupts a
    different force, Sodium & Potassium Homeostasis — explains the DKA
    potassium paradox and its clinical treatment-safety implications)
73. Reproductive Physiology — 2/2 (completes the ENTIRE Systemic Health
    Physiology section: Hypothalamic-Pituitary-Gonadal Axis & the Menstrual
    Cycle — explains PCOS's LH:FSH disruption mechanism, Physiologic Changes
    of Pregnancy — explains preeclampsia as fundamentally a placental
    vascular disorder producing systemic maternal endothelial dysfunction,
    including its ocular manifestations)
74. Bioenergetics & Energy Storage — 3/3 (Glycogen Synthesis & Breakdown, Fat
    Storage & Mobilization, Fed vs. Fasting State Metabolism — gives the
    complete biochemical explanation for why DKA produces severe
    hyperglycemia despite cellular glucose starvation, and why its
    ketoacidosis differs mechanistically from normal fasting ketosis; ties
    to existing Diabetes Mellitus and Obesity/Metabolic Syndrome content)
75. Molecular Biology — 3/3 (DNA Structure & Replication, Transcription &
    Translation, Mutation Types & Functional Consequences — the
    loss-of-function/gain-of-function distinction directly explains why
    tumor suppressor mutations are recessive (two-hit hypothesis) while
    oncogene mutations are dominant, and why inherited tumor-suppressor
    mutations so dramatically raise cancer risk; extends existing Genetic
    Principles and Oncogenes & Tumor Suppressor Genes content)
76. Carbohydrate Biochemistry — 3/3 (built this session: Glycolysis — Pathway
    & Regulation, Gluconeogenesis & the Cori Cycle, Pentose Phosphate
    Pathway & NADPH — gives the enzyme-level (PFK-1) explanation for the
    "hyperglycemia with cellular glucose starvation" paradox in diabetes,
    and the G6PD deficiency/oxidative hemolysis mechanism directly extends
    existing Anemia content under Hematopoietic & Lymphoid System)
77. Lipid Biochemistry — 3/3 (built this session: Lipoprotein Classes &
    Cholesterol Transport, Fatty Acid Oxidation, Cholesterol Synthesis &
    Statin Mechanism — gives the complete LDL-oxidation-to-foam-cell
    mechanism underlying existing Atherosclerosis content, and the full
    statin mechanism of action; also completes the biochemical chain from
    lipolysis through beta-oxidation to ketogenesis)
78. Protein Biochemistry — 2/2 (built this session: Collagen Structure &
    Synthesis — vitamin C/scurvy mechanism, useful contrast to existing
    Marfan Syndrome content; Protein Folding & Structural Levels — explains
    genotype-phenotype severity spectrum for missense mutations, extending
    existing Mutation Types content)
79. Cellular Biochemistry — 3/3 (built this session: Enzyme Kinetics &
    Inhibition — precise competitive/noncompetitive vocabulary for statins
    and other drug mechanisms already covered, Second Messenger Systems
    (cAMP, IP3/DAG) — unifying GPCR signaling framework for beta-adrenergic/
    alpha-1 adrenergic drug effects already relevant to Cardiovascular and
    Glaucoma content, Free Radicals & Antioxidant Defense — biochemical
    rationale for AREDS2 supplementation, extending existing AMD content)
80. Nutritional Biochemistry — 2/2 (Fat-Soluble Vitamin Metabolism (A, D, E,
    K) — ties vitamin A directly to the visual cycle chromophore already
    covered, and explains why cirrhosis causes combined A/D/K deficiency
    risk; Water-Soluble Vitamin Coenzyme Functions — gives the key
    B12-vs-folate distinguishing feature (neurologic involvement) for
    megaloblastic anemia, extending existing Anemia content. Completes the
    ENTIRE Systemic Health Biochemistry section, 7/7.)
81. Antibody Structure & Function — 2/2 (built this session, FIRST
    Immunology-discipline topic on the platform: Antibody Structure &
    Classes (IgG/IgM/IgA/IgE/IgD) — gives the structural mechanism behind
    existing Type I Hypersensitivity's IgE-mediated mast cell degranulation
    and IgM-vs-IgG serology interpretation relevant to ocular toxoplasmosis;
    Antibody Function & Complement Activation — gives the classical
    complement pathway mechanism distinguishing Type II from Type III
    hypersensitivity, extending existing SLE content)
82. Adaptive (Specific) Immunity — 3/3 (T-Cell Subsets & Cell-Mediated
    Immunity — explains exactly why HIV's CD4+ depletion produces such broad
    immunodeficiency (CD4+ cells coordinate B cells, CD8+ cells, and
    macrophages) and gives the T-cell-mediated mechanism of Type IV
    hypersensitivity; MHC Class I/II & Antigen Presentation — explains
    transplant rejection mechanism and corneal graft relative immune
    privilege, extending existing Cornea content; B-Cell Activation &
    Humoral Immunity — explains why HIV impairs antibody responses too, not
    just cell-mediated immunity, via CD4+-dependent B-cell co-stimulation)
83. Autoimmunity — 1/1 (built this session: Immune Tolerance & Mechanisms of
    Autoimmune Breakdown — central vs. peripheral tolerance framework,
    molecular mimicry, and the defective-apoptotic-clearance mechanism
    proposed for SLE's antinuclear/anti-dsDNA antibodies, extending existing
    SLE content)
84. Tumor Immunology — 1/1 (built this session: Tumor Immune Surveillance &
    Immune Evasion — CD8+ T-cell/NK-cell overlapping surveillance, tumor
    evasion strategies including immune checkpoint expression, and why
    immunosuppression is a cancer risk factor; extends existing Neoplasia/
    Oncogenes/Metastasis content, sets up the NK cell "missing self"
    mechanism used in the next topic)
85. Nonspecific (Innate) Immunity — 3/3 (Physical & Chemical Barrier
    Defenses — explains why dry eye/lagophthalmos are genuine infection
    risks, not just comfort issues, via loss of tear film's dual
    mechanical/lysozyme defense; Complement System — Three Activation
    Pathways — introduces the antibody-independent alternative and lectin
    pathways alongside the classical pathway already covered under Antibody
    Function; Natural Killer Cells & Interferons — the "missing self"
    mechanism explaining why MHC-downregulating tumor evasion is a
    trade-off, not risk-free, directly extending Tumor Immunology)
86. Cytokines — 1/1 (built this session: Cytokine Signaling & the Th1/Th2
    Balance — unifying immunologic lens explaining why atopic conditions
    like allergic conjunctivitis cluster together (Th2-skewed) while
    granulomatous conditions like sarcoidosis reflect a distinct Th1-skewed
    pattern)
87. Antigen-Antibody Interactions — 1/1 (built this session: Antibody
    Affinity/Avidity & Diagnostic Immunoassays — explains the sensitive-
    screen-then-specific-confirmation testing logic behind HIV serology
    already covered, and the immunofluorescence-pattern basis of ANA testing
    relevant to existing SLE content)
88. Antigens — 1/1 (built this session: Antigens, Haptens, & Epitope
    Recognition — hapten mechanism explains certain drug-induced
    hypersensitivity reactions relevant to ophthalmic pharmacology)
89. Tissue Transplantation & Graft Rejection — 1/1 (built this session,
    effectively completes the Systemic Health Immunology section, 9/10 NBEO
    slots — see note above re: Complement's intentionally-skipped standalone
    slot: Types of Graft Rejection & Immunosuppressive Strategies —
    hyperacute/acute/chronic rejection classification, and explains why
    corneal transplants typically avoid the aggressive systemic
    immunosuppression required for solid organs, extending existing
    MHC/corneal immune privilege content)
90. Bacteriology — 2/2 (built this session, FIRST Microbiology-discipline
    topic on the platform: Bacterial Structure & Gram Stain Classification —
    gram-positive/negative distinction directly explains empiric antibiotic
    selection for Pseudomonas-associated contact lens keratitis already
    covered; Antibiotic Mechanisms of Action & Resistance — explains why
    fluoroquinolones are chosen empirically for suspected bacterial
    keratitis before culture results)
91. Virology — 2/2 (built this session: Viral Structure & Replication
    Cycle — the latency mechanism directly explains why HSV keratitis,
    already covered, is characteristically recurrent rather than a one-time
    infection; Antiviral Drug Mechanisms & Latency — explains why acyclovir
    treats active HSV disease but cannot eliminate the latent trigeminal
    ganglion reservoir, extending existing HSV Keratitis management content)
92. Mycology — 2/2 (built this session, introduces a genuinely NEW clinical
    topic not covered elsewhere: Fungal Structure & Classification (Yeasts
    vs. Molds); Fungal Keratitis — Risk Factors & Clinical Distinction —
    classic vegetative trauma risk factor and feathery infiltrate margins,
    with a critical diagnostic-pitfall connection to existing HSV stromal
    keratitis corticosteroid management content — corticosteroids can
    dramatically worsen undiagnosed fungal keratitis)
93. Parasitology — 1/1 (introduces a genuinely NEW clinical topic, COMPLETES
    THE ENTIRE Systemic Health Microbiology section, 4/4: Acanthamoeba
    Keratitis — Pathophysiology & Clinical Distinction — contact lens + water
    exposure risk factor connecting directly to existing Contact Lens
    Complications content, and the classic pain-disproportionate-to-signs
    distinguishing feature from HSV keratitis, a genuinely high-yield
    misdiagnosis-prevention topic)
94. Head & Neck Anatomy — 2/2 (built this session, FIRST Anatomy-discipline
    topic on the platform: Cranial Nerves Relevant to Vision & Ocular
    Motility (II, III, IV, V, VI, VII) — gives the pupil-sparing vs.
    pupil-involving CN III palsy localization distinction, directly
    extending existing diabetic microvascular cranial neuropathy content;
    Carotid Arterial Supply to the Eye & Brain — traces the exact arterial
    pathway explaining why Amaurosis Fugax, already covered, is treated as
    a genuine stroke-risk emergency)
95. Diencephalon — 2/2 (built this session: Thalamus & the Lateral
    Geniculate Nucleus — gives the monocular/bitemporal/homonymous visual
    field defect localization framework, extending existing Pituitary
    Adenoma bitemporal hemianopia content; Hypothalamus — Autonomic &
    Endocrine Control Center — gives the complete anatomic basis for the
    hypothalamic-pituitary axis already used throughout existing Endocrine
    and Reproductive Physiology content)
96. Neurohistology — 2/2 (Neuron Structure & Glial Cell Types — cellular/
    structural correlate to existing Nerve Cell Electrophysiology content;
    Myelination — Oligodendrocytes vs. Schwann Cells — explains precisely
    why MS, already covered, spares peripheral nerve function, and why CNS
    injuries including optic nerve damage carry worse regenerative
    prognosis than peripheral nerve injuries. Note: this was the FIRST
    Anatomy-discipline content on the platform, alongside Head & Neck and
    Diencephalon built the same session.)
97. Autonomic Nervous System Anatomy — 2/2 (built this session: Sympathetic
    Pathway Anatomy — the full three-neuron oculosympathetic chain (central,
    preganglionic via lung apex, postganglionic via internal carotid artery)
    giving the complete anatomic basis for existing Horner Syndrome content
    and explaining why painful acute Horner syndrome demands urgent carotid
    dissection workup; Parasympathetic Pathway Anatomy — Edinger-Westphal to
    iris sphincter, explaining precisely why the peripheral position of
    parasympathetic fibers within CN III causes the pupil-sparing
    (microvascular) vs. pupil-involving (compressive) distinction already
    referenced under Head & Neck Anatomy's CN III palsy content, plus the
    pilocarpine pharmacologic testing distinction)
98. Medulla — 2/2 (built this session: Lower Cranial Nerve Nuclei (IX, X, XI,
    XII) & Brainstem Localization — explains Wallenberg (lateral medullary)
    syndrome's full multi-system finding cluster as one small PICA-territory
    lesion, directly incorporating the Sympathetic Pathway content built
    the same session; Medullary Vital Centers — cardiac/respiratory/
    vasomotor control, explaining why medullary compression is a true
    neurologic emergency unlike many cortical lesions)
99. Pons — 2/2 (Pontine Cranial Nerve Nuclei (V, VI, VII, VIII) — explains
    the combined CN VI/VII deficit pattern distinguishing central pontine
    lesions from peripheral Bell's palsy; The Medial Longitudinal
    Fasciculus & Internuclear Ophthalmoplegia — gives the COMPLETE
    mechanistic explanation for INO, a finding already referenced under
    existing MS content but never before explained anatomically on this
    platform — the preserved-convergence distinguishing feature is
    genuinely high-yield)
100. Midbrain — 2/2 (CROSSED THE 100-TOPIC MILESTONE: Midbrain Structures —
    CN III/IV Nuclei & the Superior Colliculus — the CN IV dorsal-exit/
    contralateral-innervation anatomic quirk; Dorsal Midbrain (Parinaud)
    Syndrome & Light-Near Dissociation — a genuinely NEW, classic,
    high-yield neuro-ophthalmic syndrome not covered elsewhere, with a
    clean differential-diagnosis distinction from Argyll Robertson pupil
    for the shared light-near dissociation finding)
101. Cerebrum — 2/2 (built this session: Cerebral Lobes & the Primary
    Visual Cortex — gives the precise anatomic explanation for macular
    sparing in occipital lesions, a high-yield localizing sign extending
    existing homonymous hemianopia and CVI content; Frontal Eye Fields &
    Voluntary Gaze Control — the "eyes toward cortical lesion, away from
    pontine lesion" bedside localization rule, connecting directly to
    Pons content)
102. Cerebellum — 1/1 (built this session: Cerebellar Structure, Function, &
    Ocular Motor Control — establishes the cerebellum's ipsilateral
    organizational principle (opposite of cerebral hemispheres), explaining
    precisely why Wallenberg syndrome's ataxia finding, already covered, is
    ipsilateral while its sensory findings are crossed)
103. Cerebral Blood Supply — 2/2 (built this session: The Circle of Willis &
    Cerebral Arterial Territories — maps ACA/MCA/PCA territories directly
    onto existing occipital/homonymous hemianopia content, explaining
    macular sparing's vascular basis; Stroke Syndromes by Vascular
    Territory — a genuinely integrated synthesis topic tying together
    virtually all of this session's Anatomy content into one
    stroke-localization framework)
104. Spinal Cord — 2/2 (built this session, COMPLETES THE ENTIRE Systemic
    Health Neuroanatomy sub-discipline, 9/9: Spinal Cord Tract Organization
    — gives the COMPLETE anatomic explanation for Wallenberg syndrome's
    crossed sensory pattern via differential corticospinal/spinothalamic
    crossing levels, finally fully explaining a finding referenced since
    the Medulla topic; Spinal Cord Syndromes & Lesion Localization —
    Brown-Séquard syndrome as a direct, derivable consequence of the
    tract-crossing principle, plus connects to existing MS content's
    spinal cord involvement and clinical heterogeneity)
105. Systemic Circulation of Blood & Lymph — 1/1 (built this session:
    Venous Return & the Lymphatic System — explains why the lymphatic
    system is the classic metastatic spread route for carcinomas already
    covered under Neoplasia/Metastasis content)
106. Generalized Cell — 2/2 (built this session: Cell Organelles — mitochondrial
    cristae as the physical site of the ETC already covered, peroxisomal
    catalase as the physical site of antioxidant defense already covered;
    Nucleus/ER/Golgi — complete secretory pathway connecting existing
    Molecular Biology transcription/translation content to actual protein
    production/secretion)
107. Tissue Types — 2/2 (built this session: Epithelial & Connective Tissue
    Classification — explains why superficial corneal abrasions heal
    without scarring while deep stromal injuries scar; Muscle & Nervous
    Tissue — explains why extraocular muscles are voluntary (skeletal) while
    iris/ciliary muscles are involuntary (smooth), connecting to existing
    Sympathetic/Parasympathetic Pathway Anatomy content)
108. Organ Systems Histology — 2/2 (built this session: Epithelial Linings
    of Major Organ Systems — unifying surface-area-maximization principle
    across renal tubule/small intestine/respiratory epithelium already
    covered separately; Glandular Tissue — pancreas as a genuinely
    instructive "mixed gland" example, explaining chronic pancreatitis's
    dual malabsorption/diabetes presentation)
109. Thorax — 2/2 (built this session: Heart Chambers, Valves, & Coronary
    Circulation — explains the anatomic basis for left vs. right heart
    failure's distinct symptom patterns already covered under CHF, and maps
    LAD territory to existing Atherosclerosis content; Lung Lobes, Pleura,
    & the Mediastinum — right-mainstem-bronchus aspiration anatomy, and the
    anatomic-concentration principle explaining mediastinal mass symptom
    clusters)
110. Abdomen & Pelvis — 2/2 (built this session, COMPLETES THE ENTIRE
    Systemic Health Anatomy discipline, 17/17 — see verification note
    above: GI Tract Organization & the Peritoneal Cavity — anatomic basis
    of hiatal hernia's contribution to existing GERD content;
    Liver/Biliary/Renal Anatomy — complete anatomic explanation for portal
    hypertension's ascites/varices in existing Cirrhosis content, and the
    biliary obstruction-to-jaundice pathway)
111. Head & Neck Pathology — 2/2 (built this session, distinct from the
    Anatomy Head & Neck topic: Sinusitis & Its Orbital Complications —
    lamina papyracea anatomy explains ethmoid sinusitis's orbital spread,
    with the preseptal-vs-orbital-cellulitis distinction a genuine ocular
    emergency skill; Salivary Gland & Thyroid Nodule Pathology —
    establishes the "nerve involvement = malignant invasion" red-flag
    pattern, connecting to existing Head & Neck Anatomy's facial nerve
    content)
112. Congenital & Hereditary Conditions — 2/2 (built this session:
    Neurofibromatosis (Type 1 & 2) — Lisch nodules distinguish NF1 from
    NF2's bilateral vestibular schwannomas, a genuine diagnostic role for
    the eye exam; Tuberous Sclerosis Complex — retinal astrocytic
    hamartoma as another example of the eye exam's diagnostic contribution
    to systemic genetic disease recognition, paralleling the NF1/Lisch
    nodule pattern)
113. Anomalies of Child Development (Systemic) — 2/2 (built this session,
    distinct from the Visual & Human Development area's version: Fetal
    Alcohol Spectrum Disorder — optic nerve hypoplasia as a potentially
    visually significant finding; Failure to Thrive — Systemic Causes —
    galactosemia's osmotic cataract mechanism directly parallels the
    diabetic sorbitol-driven cataract mechanism already covered)
114. Anomalies of the Aging Adult (Systemic) — 2/2 (built this session,
    distinct from the Visual & Human Development area's version, COMPLETES
    THE ENTIRE Systemic Health Pathology discipline and, with it, ALL of
    Systemic Health across all 8 disciplines — a genuinely verified,
    complete milestone: Frailty & Fall Risk in the Aging Adult — positions
    cataract surgery/refraction/glaucoma management as genuine
    fall-prevention interventions; Polypharmacy & Age-Related
    Pharmacokinetic Changes — connects declining renal/hepatic clearance,
    already covered functionally, to real ocular side-effect risk from
    systemic medications like hydroxychloroquine and amiodarone)
115. Radiation & the Eye — 2/2 (built this session, FIRST Major Category A /
    Ametropia topic: UV Radiation Spectrum & Ocular Tissue Effects — UVB
    surface damage vs. UVA lens penetration, extending existing
    Pterygium/Pinguecula and Cataract content; Acute UV Injury —
    Photokeratitis & Solar Retinopathy — the epithelium-regenerates/
    retina-doesn't prognostic distinction, extending existing Tissue Types
    content)
116. Schematic Eye Models — 2/2 (built this session, FIRST calculation/
    worked-example topic on the platform: The Reduced Eye Model — D=n'/f'
    formula with worked numeric examples connecting directly to
    myopia/hyperopia already covered under Refractive States; Gullstrand's
    Schematic Eye & Cardinal Points — nodal points, sets up magnification
    calculations)
117. Dioptrics of the Eye — 2/2 (built this session: Component Refracting
    Powers — cornea ~70%/lens ~30% split explains both LASIK's outsized
    effect from modest corneal change AND why pseudophakic patients lose
    accommodation, extending existing IOL/Cataract content; Far Point &
    Near Point — the reciprocal spectacle-power formula with worked
    examples, directly extending Refractive States)
118. Image Quality — 2/2 (built this session, COMPLETES THE ENTIRE
    Ametropia > Optics(Physiological) section, 6/6: Factors Degrading
    Retinal Image Quality — the aberration/diffraction pupil-size tradeoff
    explains WHY pinhole testing aperture size is deliberately chosen, not
    just that it works; Visual Acuity Measurement & MAR — the
    Snellen-fraction-to-angular-resolution formula with worked examples,
    directly connecting acuity notation to low vision magnification
    estimation)
119. Refraction at Single Spherical/Plane Surfaces — 2/2 (built this
    session, FIRST Optics(Geometrical) topic: Vergence & the Single
    Refracting Surface Equation — V=U+P, the foundational equation
    underlying every other optics calculation on the platform, with a full
    worked numeric example; Plane Surfaces & Apparent Depth — explains why
    underwater vision blurs without goggles, extending existing Component
    Refracting Powers content)
120. Thin Lenses — 2/2 (built this session: The Thin Lens Vergence Equation
    & Image Formation — real vs. virtual image worked examples,
    establishing the magnifier principle; Linear Magnification & Image
    Characteristics — m=U/V with worked examples, directly extends the
    low-vision-magnifier concept from Image Quality's MAR content with an
    actual quantitative magnification calculation)
121. Thin Prisms — 2/2 (built this session, distinct from the Ophthalmic
    Prisms/Prentice's Rule topic already built: Prism Deviation & the
    Prism Diopter Definition — gives the physical origin (apex angle,
    refractive index) of the prism diopter unit used in the existing
    Prentice's Rule topic; Combining Prisms & Resultant Prism Power —
    vector/Pythagorean addition for compound prism prescriptions, a
    genuinely practical calculation using 3-4-5 and 5-12-13 triangles)
122. Thick Lenses — 1/1 (built this session: Back Vertex Power & Front
    Vertex Power — explains why the thin lens model breaks down for
    high-power aphakic corrections, extending existing Aphakia content and
    setting up why vertex distance matters clinically for high-power
    lenses)
123. Spherocylindrical Lenses — 2/2 (built this session: Sphere/Cylinder
    Notation & Transposition — a genuinely practical calculation skill
    (plus/minus cylinder conversion) for comparing prescriptions across
    conventions; Obliquely Crossed Cylinders — the trigonometric
    combination formula (verified against three test cases), extending
    existing Astigmatism content with real quantitative depth relevant to
    toric IOL calculations)
124. Aberrations — 2/2 (built this session: Spherical Aberration & Coma —
    explains aspheric IOL contrast-sensitivity benefits and why keratoconus
    patients report distortion despite accurate refraction, both already
    covered; Chromatic Aberration & the Achromatic Doublet — Abbe number
    concept gives a genuine patient-counseling point about high-index lens
    material trade-offs)
125. Stops, Pupils, & Ports — 1/1 (built this session: Entrance Pupil, Exit
    Pupil, & Aperture/Field Stops — explains why the clinically observed
    pupil is ~13% larger than the true anatomic pupil, via the cornea's
    magnifying effect already covered under Component Refracting Powers)
126. Ophthalmic & Optical Instruments — 1/1 (built this session, COMPLETES
    THE ENTIRE Optics(Geometrical) section, 8/8: The Direct Ophthalmoscope
    — Optical Principles — a genuinely new instrument-optics topic not
    covered elsewhere, explaining magnification/field-of-view properties
    via the entrance pupil concept just covered, and the lens wheel's
    combined-refractive-error compensation mechanism as a direct
    application of the vergence equation)
127. Wave Optics — 2/2 (built this session: Interference & Diffraction —
    completes the wave-based physical explanation for the Airy disk/
    diffraction-limited resolution concept already introduced under Image
    Quality, and explains the AR coating destructive-interference
    mechanism; Polarization of Light — Malus's law with a verified worked
    example, giving the complete physical mechanism behind polarized
    sunglasses already referenced under existing Spectacle Lens/Aging
    content, closing a previously-dangling cross-reference)
128. Interaction of Light & Matter — 2/2 (built this session, COMPLETES THE
    ENTIRE AMETROPIA CONDITION AREA, 16/16 — Optics Physiological 6/6 +
    Optics Geometrical 8/8 + Optics Physical 2/2: Absorption, Transmission,
    & Reflection — explains why nuclear sclerotic cataracts affect blue
    color perception via progressive short-wavelength lens absorption,
    extending existing Cataract content; Scattering (Rayleigh & Mie) —
    extends existing Corneal Transparency content by explaining WHY corneal
    edema/scarring produces grayish rather than blue-tinted haze, a
    genuinely satisfying physics-to-clinical-appearance connection)
129. Eye Movements — 2/2 (built this session, first topic in the
    Accommodation/Vergence/Oculomotor Function condition area beyond
    Accommodation itself: Saccades & Smooth Pursuit — two distinct voluntary
    systems with genuine localizing value, extending existing Cerebellum
    and Frontal Eye Field content; Vestibulo-Ocular Reflex & Optokinetic
    Nystagmus — objective, cooperation-independent tools for assessing
    vestibular/brainstem integrity and detecting functional non-organic
    vision loss)
130. Pupils — Clinical Anomalies — 2/2 (built this session, distinct from
    the existing Pupillary Pathway Clinical Testing topic — RAPD/
    Anisocoria/Horner already covered there: Adie's Tonic Pupil — a
    genuinely NEW topic not covered elsewhere, giving a PERIPHERAL
    mechanism for light-near dissociation distinct from the CENTRAL
    dorsal-midbrain mechanism already covered; Pharmacologic Pupil Testing
    — unifies the denervation-supersensitivity principle shared by the
    dilute-pilocarpine/Adie's test and the apraclonidine/Horner test, both
    previously introduced separately)
131. Anomalies of Eye Movements — 1/1 (built this session: Acquired
    Nystagmus — Localizing Patterns — downbeat (craniocervical junction/
    Chiari), upbeat (medulla), and see-saw (diencephalon/suprasellar,
    e.g., large pituitary tumors already covered) nystagmus, each with
    distinct anatomic localization; completes 3 of 4 Optics(Physiological)
    subtopics in the Accommodation/Vergence/Oculomotor Function area)
132. Keratometry & Corneal Topography Instruments — 2/2 (built this
    session, completes Contact Lenses' last unbuilt subtopic slot:
    Keratometry — mire reflection principle and the 1.3375 keratometric
    index calibration workaround, directly extending existing Component
    Refracting Powers content; Corneal Topography — Placido disc vs.
    elevation-based (Scheimpflug) systems, explaining why elevation-based
    topography is preferred for refractive surgery screening given its
    ability to detect early posterior corneal changes, extending existing
    Keratoconus and LASIK/PRK screening content)
133. Accommodation/Vergence Pharmacology — 2/2 (built this session,
    COMPLETES THE ENTIRE Accommodation/Vergence/Oculomotor Function
    condition area, 5/5 subtopics: Mydriatics & Cycloplegics — Mechanisms
    & Duration of Action — anticholinergic vs. adrenergic mechanisms
    explain why phenylephrine alone is inadequate for cycloplegic
    refraction, and why it's combined with tropicamide for complete
    dilation; Miotics — Direct & Indirect Cholinergic Agonists —
    explicitly connects indirect-acting miotic mechanism to the same
    acetylcholinesterase-inhibition principle already covered under
    Myasthenia Gravis treatment)
134. Spectacle Lens Reflection & Coatings — 2/2 (built this session, closes
    the one genuine remaining gap in Ophthalmic Optics/Spectacles — see
    correction note above: Anti-Reflective Coating — Mechanism & Clinical
    Trade-offs — applies the destructive-interference principle already
    covered under Wave Optics to a concrete dispensing context, and
    explains why AR coating benefit scales with lens index via the
    Fresnel reflection principle already covered under Interaction of
    Light & Matter; Mirror Coatings & UV-Reflective Treatments —
    establishes tint/mirror coating/UV protection as three INDEPENDENTLY
    specified lens properties, a genuinely important patient-safety
    counseling point extending existing Radiation & the Eye and
    Absorptive Lens content)

## NOT YET STARTED — 130 remaining topics
- **MILESTONE**: Systemic Health is fully, verifiably 100% COMPLETE across
  ALL 8 disciplines (see prior session notes above). This is the largest
  single major condition area on the platform, and it is genuinely done.
- **MILESTONE**: Ametropia is fully, completely done — 16/16 topics across
  all three optics sub-disciplines. The first complete Major Category A
  area.
- **MILESTONE**: Accommodation/Vergence/Oculomotor Function is fully,
  completely done — 5/5 subtopics. The second complete Major Category A
  area (after Ametropia).
- **MILESTONE**: Contact Lenses is essentially fully complete — 5 topics
  covering Complications, Fitting & Selection, Optical Characteristics,
  Pharmacology, and Keratometry/Topography Instruments.
- **CORRECTION (verified this session)**: Visual & Human Development was
  ALREADY FULLY COMPLETE before this session — all 5 subtopics built
  (Vision Development in the Infant/Child, Effects of Early Environmental
  Restrictions, Changes in Vision with Aging, Vision Perceptual-Motor
  Skills, Anomalies of Child Development) at t-7-0-0 through t-7-0-4. This
  was NOT known/reflected in earlier session notes — PROGRESS.md had
  listed it as needing verification or building; it does not.
- **CORRECTION (verified this session)**: Ophthalmic Optics/Spectacles was
  ALSO already substantially built (6 topics) before this session, and is
  now FULLY complete after this session's Reflection & Coatings addition
  (7 topics total: Optical Characteristics, Prisms/Prentice's Rule,
  Multifocal Lenses, Frame Fitting, High-Powered Lens Considerations,
  Impact Resistance/ANSI standards, Reflection & Coatings).
- Low Vision already has a full 3-objective topic built — confirmed
  complete in a prior session's verification pass.
- **REMINDER (recurring theme this session, still relevant)**: always
  grep-verify existing topic coverage (`grep -n "TOPIC_ID = \"t-{area}-"`)
  before assuming a condition area needs building — this session found
  and corrected THREE separate stale/incorrect PROGRESS.md claims (Contact
  Lenses, Low Vision, Ophthalmic Optics/Spectacles, Visual & Human
  Development). PROGRESS.md's prose "coverage status" claims have proven
  unreliable multiple times; the file itself is ground truth.
Notably untouched or under-covered condition areas (highest priority for
next session, in rough suggested order):
- **Given the pattern of stale claims discovered this session, the FIRST
  step next session should be a comprehensive grep-based audit**: for
  every area listed in the AREAS array (search `{ area: "` near the top of
  the file), grep for `TOPIC_ID = "t-{index}-` to get an accurate picture
  of what's actually built vs. not, rather than trusting any remaining
  "notably untouched" claims below, which may also be stale.
- Perceptual Function/Color Vision cluster is already 100% complete (Space,
  Form, Light, Motion perception + Color Vision all built) — confirmed
  correct in earlier sessions.
- Emergencies/Trauma — no dedicated topic exists yet; needs a tagging strategy
  since the outline says it's "embedded" in other areas (see open question
  below). This claim has not been re-verified this session.
- With this session's corrections, essentially ALL of Major Category A now
  appears complete or near-complete: Ametropia (done), Accommodation/
  Vergence (done), Contact Lenses (done), Low Vision (done), Ophthalmic
  Optics/Spectacles (done), Visual & Human Development (done), Perceptual
  Function/Color Vision (done). **The next session should verify Amblyopia/
  Strabismus** (a Major Category A area not yet grep-checked this session)
  and then, if Major Category A is indeed fully complete, pivot to Major
  Category B condition areas (Lids/Lashes/Lacrimal/Adnexa/Orbit and
  beyond) using the same audit-first approach.

## Immediate next steps (pick up here)
1. **FIRST: run a comprehensive grep-based audit of ALL condition areas**
   before building anything — this session discovered that at least 4
   areas previously believed to be empty or partially built were actually
   complete or near-complete. Search the AREAS array near the top of the
   file for every `{ area: "..."` entry, note its numeric index, then grep
   `TOPIC_ID = "t-{index}-"` for each to get accurate current coverage.
   This audit should take priority over jumping straight into new content.
2. Based on this session's findings, Major Category A is likely at or near
   100% complete. Good next moves, in rough priority order:
   a. Verify Amblyopia/Strabismus condition area's actual status (not yet
      checked this session).
   b. If Major Category A is confirmed complete, pivot to Major Category B
      (Lids/Lashes/Lacrimal System/Ocular Adnexa/Orbit is the first B-area
      listed) — audit its actual coverage first, since this platform
      already has substantial ocular-structure content built under various
      "Physiology" topics referenced throughout Systemic Health
      cross-references (e.g., EOMPHYS, TEARPHYS already exist) — check
      what Anatomy/Pathology coverage exists there before assuming gaps.
3. Decide on an Emergencies/Trauma tagging strategy (see open question
   below) — since the NBEO outline treats this as "embedded" across other
   topics rather than a standalone section.

## Validation tooling (recreate if needed in a future session)
- `/home/claude/integrity_check.py` — a regex-based Python script (not a real
  JS parser) that checks: orphaned objectiveIds across STUDY_PAGES/
  FLASHCARDS/QUESTIONS vs. all `*_OBJECTIVES` arrays; duplicate STUDY_PAGES
  keys; duplicate flashcard/question ids; duplicate topic id string values;
  objectives with built:false. Run via `python3 integrity_check.py
  nbeo-app.jsx`. Exits 0 with "ALL CHECKS PASSED" on success, exits 1 and
  lists errors otherwise. This script is NOT saved to outputs (it's a dev
  tool) — a future session should recreate it from this description if it
  isn't found in the working directory (it won't persist since the sandbox
  resets between sessions).
- Babel syntax check: `npm install -g @babel/core @babel/preset-react
  @babel/cli` (into `/home/claude/.npm-global`, already in PATH), then run
  `babel.transformFileSync('nbeo-app.jsx', { presets:
  ['@babel/preset-react'] })` via a small Node script. The ">500KB" babel
  deoptimization note is cosmetic only, not an error.

## Open questions / decisions not yet made
- How to represent Emergencies/Trauma (8-14 items) given it's explicitly "embedded"
  in other condition areas per the outline, not a standalone topic.
- What content shape non-Pathology disciplines (Anatomy, Physiology, Biochemistry,
  Immunology, Microbiology) should take — they're not disease-objective-shaped the
  way Pathology topics are. Likely needs mechanism/structure-based study page
  sections rather than Learn It/Memorize It/Apply It framed around a named disease.
- Whether/when to do an actual source-verification pass (everything is currently
  UNDER REVIEW, not VERIFIED).

## Automation note
User attempted to set up Claude Cowork scheduled tasks for autonomous continuation
but decided to skip it (as of this session) in favor of manually continuing in this
chat. If automation is revisited later, PROJECT_SPEC.md already contains the full
content pipeline and validation script needed for an autonomous session to follow.

## File locations
- Working copy during a session: `/home/claude/nbeo-app.jsx`
- Deployed/presented copy: `/mnt/user-data/outputs/nbeo-app.jsx`
- **IMPORTANT**: This sandbox resets between sessions. A future session MUST start
  by re-uploading/re-fetching the current `nbeo-app.jsx` (get it from the user's
  most recent download) — it does NOT persist automatically between separate
  conversations.
